Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisa Zimmer

Showing results (1-10 of 218) with videos related to

Pageof 22
Sort By:
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|October 16, 2023
Neues ADO-Komitee "Survivorship"Andrea Forschner, Lisa Zimmer
Dermatologie (Heidelberg, Germany)|June 4, 2024
[Side effects of oncologic therapies]Lisa Zimmer, Jessica C Hassel
Dermatologie (Heidelberg, Germany)|May 27, 2024
[Side effects of dermato-oncologic therapies]Jessica C Hassel, Lisa Zimmer
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|June 1, 2007
Health services research in dermatology--current update and perspectivesLisa Zimmer, Angela Schommer, Matthias Augustin
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|November 26, 2013
[23rd Annual Meeting of the Dermatologic Oncology Association (ADO)--German Skin Cancer Congress in Essen]Julia Vaubel, Uwe Hillen, Lisa Zimmer
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|March 22, 2012
Current advances and perspectives in the treatment of advanced melanomaElisabeth Livingstone, Lisa Zimmer, Julia Vaubel, et al.
Chinese Clinical Oncology|April 6, 2015
BRAF, MEK and KIT inhibitors for melanoma: adverse events and their managementElisabeth Livingstone, Lisa Zimmer, Julia Vaubel, et al.
Expert Opinion on Investigational Drugs|October 15, 2010
PLX4032: does it keep its promise for metastatic melanoma treatment?Elisabeth Livingstone, Lisa Zimmer, Sarah Piel, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|May 11, 2012
Side effects of systemic oncological therapies in dermatologyLisa Zimmer, Julia Vaubel, Elisabeth Livingstone, et al.
Current Oncology Reports|April 2, 2023
The Latest Option: Nivolumab and Relatlimab in Advanced MelanomaLea Jessica Albrecht, Elisabeth Livingstone, Lisa Zimmer, et al.
Pageof 22

Showing results (1-10 of 218) with videos related to

Sort By:
Pageof 22
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|October 16, 2023
Neues ADO-Komitee "Survivorship"Andrea Forschner, Lisa Zimmer
Dermatologie (Heidelberg, Germany)|June 4, 2024
[Side effects of oncologic therapies]Lisa Zimmer, Jessica C Hassel
Dermatologie (Heidelberg, Germany)|May 27, 2024
[Side effects of dermato-oncologic therapies]Jessica C Hassel, Lisa Zimmer
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|June 1, 2007
Health services research in dermatology--current update and perspectivesLisa Zimmer, Angela Schommer, Matthias Augustin
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|November 26, 2013
[23rd Annual Meeting of the Dermatologic Oncology Association (ADO)--German Skin Cancer Congress in Essen]Julia Vaubel, Uwe Hillen, Lisa Zimmer
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|March 22, 2012
Current advances and perspectives in the treatment of advanced melanomaElisabeth Livingstone, Lisa Zimmer, Julia Vaubel, et al.
Chinese Clinical Oncology|April 6, 2015
BRAF, MEK and KIT inhibitors for melanoma: adverse events and their managementElisabeth Livingstone, Lisa Zimmer, Julia Vaubel, et al.
Expert Opinion on Investigational Drugs|October 15, 2010
PLX4032: does it keep its promise for metastatic melanoma treatment?Elisabeth Livingstone, Lisa Zimmer, Sarah Piel, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|May 11, 2012
Side effects of systemic oncological therapies in dermatologyLisa Zimmer, Julia Vaubel, Elisabeth Livingstone, et al.
Current Oncology Reports|April 2, 2023
The Latest Option: Nivolumab and Relatlimab in Advanced MelanomaLea Jessica Albrecht, Elisabeth Livingstone, Lisa Zimmer, et al.
Pageof 22